Inventor · disambiguated record
Steven A. Boyd
Also filed as: BOYD STEVEN · BOYD STEVEN A · BOYD STEVEN ARMEN
51 granted patents·18 pending applications·1,068 citations·filing 1991–2023
98Inventor score
Files withVENATORX PHARMACEUTICALS INC22ABBOTT LAB18ARRAY BIOPHARMA INC12AICHER THOMAS DANIEL5KNOPP BIOSCIENCES LLC3
Top patents by PatentIndex Score
69 records- 0197US11638715B2Orally-bioavailable nucleoside analogsVENATORX PHARMACEUTICALS INC·Filed 2022·Granted May 2, 2023·9 cites·30 claims
- 0297US6579882B2Cell adhesion-inhibiting antiinflammatory compoundsABBOTT LAB·Filed 2001·Granted Jun 17, 2003·189 cites·8 claims
- 0397US6232320B1Cell adhesion-inhibiting antiinflammatory compoundsABBOTT LAB·Filed 1999·Granted May 15, 2001·234 cites·25 claims
- 0496US5767144AEndothelin antagonistsABBOTT LAB·Filed 1995·Granted Jun 16, 1998·90 cites·30 claims
- 0595US9481653B2Benzoimidazol-1,2-yl amides as Kv7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2015·Granted Nov 1, 2016·15 cites·19 claims
- 0695US7365093B2Endothelin antagonistsABBOTT LAB·Filed 2005·Granted Apr 29, 2008·18 cites·1 claims
- 0794US5326776AAngiotensin II receptor antagonistsABBOTT LAB·Filed 1993·Granted Jul 5, 1994·92 cites·26 claims
- 0893US11566001B2Hepatitis B capsid assembly modulatorsVENATORX PHARMACEUTICALS INC·Filed 2021·Granted Jan 31, 2023·2 cites·11 claims
- 0993US9914708B2Benzoimidazol-1,2-yl amides as Kv7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2016·Granted Mar 13, 2018·10 cites·16 claims
- 1093US7897607B2Cyclic compoundsTAKEDA PHARMACEUTICAL·Filed 2005·Granted Mar 1, 2011·37 cites·10 claims
- 1193US6946481B1Endothelin antagonistsABBOTT LAB·Filed 2002·Granted Sep 20, 2005·37 cites·26 claims
- 1293US5250548AAngiotensin II receptor antagonistsABBOTT LAB·Filed 1992·Granted Oct 5, 1993·57 cites·16 claims
- 1392US10590076B2Hepatitis B capsid assembly modulatorsVENATORX PHARMACEUTICALS INC·Filed 2019·Granted Mar 17, 2020·6 cites·17 claims
- 1492US6162927AEndothelin antagonistsABBOTT LAB·Filed 1997·Granted Dec 19, 2000·46 cites·10 claims
- 1591US9650376B2Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2014·Granted May 16, 2017·8 cites·23 claims
- 1689US7208517B1Endothelin antagonistsABBOTT LABORTORIES·Filed 2000·Granted Apr 24, 2007·35 cites·8 claims
- 1787US10399996B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2016·Granted Sep 3, 2019·6 cites·17 claims
- 1887US8022222B2Glucokinase activatorsARRAY BIOPHARMA INC·Filed 2007·Granted Sep 20, 2011·7 cites·16 claims
- 1986US7723330B2Heterobicyclic pyrazole compounds and methods of useARRAY BIOPHARMA INC·Filed 2007·Granted May 25, 2010·11 cites·58 claims
- 2086US6462194B1Endothelin antagonistsABBOTT LAB·Filed 2000·Granted Oct 8, 2002·14 cites·9 claims
- 2186US6380241B1Treatment of diseases using endothelin antagonistsABBOTT LAB·Filed 2000·Granted Apr 30, 2002·13 cites·6 claims
- 2284US10464952B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2018·Granted Nov 5, 2019·5 cites·13 claims
- 2383US11267826B2Penicillin-binding protein inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2018·Granted Mar 8, 2022·2 cites·20 claims
- 2483US8022223B22-aminopyridine analogs as glucokinase activatorsARRAY BIOPHARMA INC·Filed 2007·Granted Sep 20, 2011·5 cites·20 claims
- 2583US8003662B2Heterobicyclic thiophene compounds and methods of useARRAY BIOPHARMA INC·Filed 2007·Granted Aug 23, 2011·9 cites·9 claims
- 2683US6878700B1Cell adhesion-inhibiting antiinflammatory and immune-suppressive compoundsABBOTT LAB·Filed 2000·Granted Apr 12, 2005·14 cites·7 claims
- 2783US5622971AEndothelin antagonistsABBOTT LAB·Filed 1995·Granted Apr 22, 1997·25 cites·22 claims
- 2881US11046716B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2019·Granted Jun 29, 2021·1 cites·20 claims
- 2981US8212045B2Pyridin-2-yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitusAICHER THOMAS DANIEL·Filed 2008·Granted Jul 3, 2012·4 cites·9 claims
- 3080US9133187B2Serine/threonine kinase inhibitorsBLAKE JAMES F·Filed 2012·Granted Sep 15, 2015·6 cites·20 claims
- 3179US11014881B2Hepatitis B capsid assembly modulatorsVENATORX PHARMACEUTICALS INC·Filed 2019·Granted May 25, 2021·1 cites·17 claims
- 3277US2023062975A1Hepatitis b capsid assembly modulatorsVENATORX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3376US6124341AEndothelin antagonistsABBOTT LAB·Filed 1998·Granted Sep 26, 2000·21 cites·36 claims
- 3476US5731434AEndothelin antagonistsABBOTT LAB·Filed 1995·Granted Mar 24, 1998·15 cites·8 claims
- 3575US8362037B22-aminopyridine analogs as glucokinase activatorsARRAY BIOPHARMA INC·Filed 2008·Granted Jan 29, 2013·2 cites·23 claims
- 3672US12102648B2Orally-bioavailable nucleoside analogsVENATORX PHARMACEUTICALS INC·Filed 2023·Granted Oct 1, 2024·0 cites·19 claims
- 3770US11247965B2Hepatitis B capsid assembly modulatorsVENATORX PHARMACEUTICALS INC·Filed 2018·Granted Feb 15, 2022·1 cites·18 claims
- 3869US8853409B2Pyridin-2yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitusAICHER THOMAS DANIEL·Filed 2012·Granted Oct 7, 2014·1 cites·32 claims
- 3966US5244910ARenin inhibitorsABBOTT LAB·Filed 1991·Granted Sep 14, 1993·8 cites·6 claims
- 4064US5268374ANon-peptide renin inhibitorsABBOTT LAB·Filed 1991·Granted Dec 7, 1993·8 cites·10 claims
- 4163US2025228882A1Orally-bioavailable nucleoside analogsVENATORX PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 4261US2025066351A1Pyrazolo[1,5-a]pyridin-2,3-yl amides as kv7 channel activatorsBIOHAVEN THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 4360US9079890B2Intermediates for the preparation of pyridin-2-yl-amino-1,2,4-thiadiazole derivativesARRAY BIOPHARMA INC·Filed 2014·Granted Jul 14, 2015·0 cites·12 claims
- 4458US2024270762A1Penicillin-binding protein inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4557US2024018166A1Sulfonyl urea nlrp3 inflammasome inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4655US12084445B2Broad-spectrum carbapenemsVENATORX PHARMACEUTICALS INC·Filed 2019·Granted Sep 10, 2024·0 cites·12 claims
- 4755US8883828B22-aminopyridine analogs as glucokinase activatorsARRAY BIOPHARMA INC·Filed 2012·Granted Nov 11, 2014·0 cites·11 claims
- 4855US8431713B22-aminopyridine derivatives as glucokinase activatorsAICHER THOMAS DANIEL·Filed 2008·Granted Apr 30, 2013·0 cites·2 claims
- 4953US2023127898A1Hepatitis b capsid assembly modulatorsVENATORX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 5052US8354540B22-aminopyridine analogs as glucokinase activatorsARRAY BIOPHARMA INC·Filed 2011·Granted Jan 15, 2013·0 cites·18 claims
Showing the top 50 of 69 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →